0000-0003-2751-985X Employment
-
Centre Hospitalier Universitaire de Lyon Medical Doctor, Hemopathology diagnosis, Coordinator of Leukemia adult and pediatric program
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (104)
- Prognostic impact of measurable residual disease in AML patients treated frontline with azacitidine and venetoclax: results from the French VENAURA registry Save
- Reporting blast percentage for response assessment in acute leukemias: recommendations from an EHA/ELN expert panel Save
- Leukemia stem cells in acute myeloid leukemia-mimicking “space and time continuum”? Save
- Myeloid neoplasm inspired intensive therapy in <scp>VEXAS</scp> syndrome: A single‐centre experience Save
- Flow MRD Monitoring Combining Laip/Dfn and CD34+CD38- LSCs Is a Strong Predictor of Outcome in Adult AML Independently of the ELN-2022 Risk: First Results from the Multicentric Acute Leukemia French Intergroup MRD Flow Network Save
- Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatment Save
- Pre-emptive detection and evolution of relapse in acute myeloid leukemia by flow cytometric measurable residual disease surveillance Save
- Tetraspanin CD81 Supports Cancer Stem Cell Function and Represents a Therapeutic Vulnerability in Acute Myeloid Leukemia Save
- Venetoclax in Combination with Intermediate Doses of Cytarabine in Consolidation Phase for Acute Myeloid Leukemia Patients in First Complete Remission; Results of the Part 1 of the Phase 1/2 Multicentric Covenidac Study Save
- Tetraspanin CD81 promotes leukemia stem cell function and represents a new therapeutic vulnerability in acute myeloid leukemia Save